Buddy Creech

December 11, 2024

Vanderbilt joins national effort to develop alphavirus vaccines

The project aims to design computational “tool kits” that can speed development of multi-virus vaccines targeting some of the greatest infectious threats to human health.

By Bill Snyder and Herschel Pollard
June 28, 2024

Antibody trial launched to address enterovirus threat

Enterovirus D68 has caused an increasing number of infections during the past decade and is associated with acute flaccid myelitis, a polio-like condition that mostly affects children and causes sudden weakness and paralysis.

By Bill Snyder
January 17, 2024

Bird flu vaccine more effective with potent adjuvant

The avian (bird) influenza vaccine creates a more robust immune response when paired with a potent ingredient known as an adjuvant, according to Vanderbilt research published in The Journal of Infectious Diseases.

By Craig Boerner
May 24, 2023

Spring event honors donors’ support and generosity

Members of Vanderbilt University Medical Center’s Canby Robinson Society recently joined CEO and President Jeff Balser, MD, PhD, and his wife, Melinda, at Cheekwood Botanic Hall for the Spring Donor Celebration, an annual event honoring donors for their loyal support.

By Nancy Humphrey
November 4, 2022

Study finds Moderna’s COVID-19 vaccine safe and effective for young children

A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.

By Bill Snyder
Pending COVID-19 samples are prepared for testing in the Diagnostic Laboratories at VUMC.
November 3, 2022

Event to spotlight VUMC’s COVID-19 research efforts

The public is invited to listen in as scientists on the forefront of COVID-19 research at Vanderbilt University Medical Center share their personal stories on Wednesday afternoon, Nov. 16, in 214 Light Hall.

By Bill Snyder
September 7, 2022

VUMC study will evaluate alternative strategies for administering mpox vaccine

Rarely fatal, the mpox virus — spread by close, often skin-to-skin contact — causes a painful, blistering rash, fever, chills and other symptoms.
By Bill Snyder
June 16, 2022

VUMC research aids approval of COVID-19 vaccine for young children

The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old as early as tomorrow, following the unanimous recommendation by an FDA advisory panel on Wednesday.
By Bill Snyder
May 12, 2022

VUMC-led study finds Moderna COVID vaccine safe and effective for children

By Bill Snyder
March 30, 2022

Uncharted days of the COVID-19 pandemic strengthen the Vanderbilt Vaccine Research Program team.

“There’s something about having a band of brothers, where you’re all focused on the same thing, and your noses are all pointed in the same direction."
By Jill Clendening
February 24, 2022

MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis

A Vanderbilt study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C).
By Kylie Avery
February 3, 2022

Study finds shorter treatment better for young children with outpatient pneumonia

A Vanderbilt study found that five days of antibiotics is superior to 10 days for children with community-acquired pneumonia who are not hospitalized.
By Craig Boerner
December 8, 2021

Weigh risks, plan ahead prior to gathering for the holidays

Vanderbilt University Medical Center infectious disease experts advise this is the season to think very wisely about planned get-togethers.
By Jill Clendening
1 2 3 4